目的探讨增食欲素A(OrexinA)通过增食欲素受体1(OX1R)和AKT/PKB信号传导途径对胰岛细胞增殖的干预效应。方法体外培养的大鼠INS-1胰岛素瘤细胞暴露于不同浓度的OrexinA,OX1R拮抗剂(SB334867)、P13K拮抗剂(渥曼青霉素)和AKT拮抗剂(PF-04691502)干预OrexinA的作用,测定INS-1的细胞增殖、凋亡、胰岛素分泌、OX1R蛋白活性及AKT蛋白磷酸化水平。结果OrexinA(10^-10-10^-6mol/L)可刺激INS-1细胞的增殖和活化,防止细胞凋亡,并增加胰岛素的分泌;OrexinA(10^-10-10^-6mol/L)增强了INS-1细胞内AKT的磷酸化,SB334867(10^-6mol/L)、渥曼青霉素(10^-8mol/L)和PF-04691502(10^-6mol/L)可以减弱OrexinA的作用。结论INS-1细胞内OrexinA通过OrexinA-OXlR的介导而活化AKT信号通路,促进细胞增殖。
Objective To investigate the interference effects of orexin A on cell proliferation of the insulin-secreting beta-cell line ( INS- 1 cells) through the orexin receptor 1 (OX1R) and the AKT/PKB signaling pathway. Methods INS- 1 cells were exposed to different concentrations of orexinA in vitro, and treated with OX 1R antagonist (SB334867), PI3K antagonist (wortmannin), or AKT antagonist (PF-04691502). The INS- 1 cell proliferation and apoptosis, insulin secretion, OX1R protein activity and AKT phosphorylation level were determined. Results Orexin A ( 10^-10 to 10^-6 mol/L) stimulated the proliferation and activation of INS- 1 cells, prevented apoptpsis, and increased insulin secretion. Additionally, AKT phosphorylation was stimulated by orexin A ( 10^-10to 10^-6 mol/L). The OXlR antagonist SB334867 ( 10^-6 mol/L), the PI3K antagonist wortmannin ( 10^-6 mol/L) and the AKT antagonist PF-04691502 ( 10^-6 mol/L) weakened the effects of orexin A. Conclusion Orexin A activated the AKT sig- naling pathway through the mediation of orexin A-OX1 R, and promoted cell proliferation in INS- 1 cells.